Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DVD: Darunavir/Ritonavir Substitution for Dual-boosted PIs
NCT00543101Phase 4Completed
- Sponsor
- Community Research Initiative of New England
- Start
- Oct 2007
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of darunavir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Community Research Initiative of New England. Primary endpoint: Percentage of Participants With Successful Virologic Suppression at 24 weeks. Started Oct 2007; status: completed.
02
Drugs
darunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00543101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00543101.